| Literature DB >> 30692829 |
Abstract
OBJECTIVE: Gallbladder polyps (GBPs) are an increasingly common incidental finding and 3% to 8% of GBPs become malignant. A poor prognosis is expected in patients with gallbladder cancer. No studies have considered the relationship between diet and the development of GBPs in the Taiwanese population. The objective of this study was to investigate whether a vegetarian diet protects against GBP development.Entities:
Keywords: Gallbladder polyps; Hepatitis B; Metabolic syndrome; Taiwan; Vegetarian diet patterns
Year: 2019 PMID: 30692829 PMCID: PMC6334569 DOI: 10.4103/tcmj.tcmj_16_18
Source DB: PubMed Journal: Ci Ji Yi Xue Za Zhi
Comparison of characteristics between different diet groups
| Characteristic | Vegan group ( | Ovo-lactovegetarian group ( | Semi-vegetarian group ( | Omnivore group ( |
|---|---|---|---|---|
| Age (years)±SD* | 62.2±9.6 | 59.1±9.1 | 59.3±9.3 | 59.3±10.4 |
| Sex, female (%)* | 729 (64.6) | 4287 (66.5) | 221 (56.8) | 1626 (43.4) |
| Smoking (%)* | 80 (7.1) | 572 (8.9) | 47 (12.1) | 693 (18.5) |
| Alcohol (%)* | 93 (8.2) | 724 (11.2) | 87 (22.4) | 1076 (28.7) |
| Betel nuts (%)* | 39 (3.5) | 194 (3.0) | 18 (4.6) | 206 (5.5) |
| Physical inactivity (%)* | 312 (27.7) | 1683 (26.0) | 103 (26.5) | 902 (24.1) |
| Systolic pressure (mmHg)* | 122.0±16.7 | 121.0±15.3 | 122.1±15.0 | 123.5±15.5 |
| Diastolic pressure (mmHg)* | 71.7±11.3 | 72.3±13.4 | 75.8±31.3 | 74.4±11.0 |
| BMI (kg/m2)* | 23.1±3.4 | 23.2±3.3 | 23.5±3.2 | 24.3±3.5 |
| Waist (cm)* | 82.1±9.4 | 81.7±9.2 | 83.1±9.2 | 85.1±9.6 |
| Body fat (%)* | 25.5±7.9 | 26.3±7.5 | 26.0±7.7 | 26.1±7.7 |
| HBsAg positive (%) | 152 (13.5) | 843 (13.1) | 50 (12.9) | 428 (11.4) |
| Anti-HCV positive (%) | 31 (2.7) | 138 (2.1) | 7 (1.8) | 80 (2.1) |
| HbA1c (%)* | 5.70±0.9 | 5.64±0.8 | 5.63±0.7 | 5.76±0.9 |
| Fasting glucose (mg/dL)* | 100.0±25.3 | 99.8±21.4 | 101.5±21.1 | 105.1±27.3 |
| Total cholesterol (mg/dL)* | 176.6±33.8 | 182.7±35.4 | 192.6±36.8 | 191.7±37.0 |
| HDL-C (mg/dL)* | 50.0±14.1 | 50.8±14.5 | 50.7±14.9 | 49.9±15.7 |
| LDL-C (mg/dL)* | 112.7±29.2 | 116.7±30.2 | 125.1±31.3 | 123.8±31.6 |
| TG (mg/dL)* | 106.2±64.8 | 108.1±67.8 | 116.0±77.3 | 117.9±75.2 |
| Gallbladder polyps (%)* | 101 (9.0) | 483 (7.5) | 28 (7.2) | 360 (9.6) |
*Statistically significant. HBsAg: Hepatitis B virus surface antigen, HCV: Hepatitis C virus, HbA1c: Hemoglobin A1c, TG: Triglycerides, BMI: Body mass index, HDL-C: High-density lipoprotein-cholesterol, LDL-C: Low-density lipoprotein-cholesterol, SD: Standard deviation
Univariate and multivariate analysis of possible risk factors for gall bladder polyps
| Variable | Gallbladder polyps | Univariate analysis, OR (95% CI) | Multivariate analysis, OR (95% CI) | |||
|---|---|---|---|---|---|---|
| Yes ( | No ( | |||||
| Age (years) | ||||||
| <30 | 3 (0.3) | 23 (0.2) | 1.000 | |||
| 30-49 | 20 (2) | 244 (2.3) | 0.878 (0.290-2.658) | 0.818 | ||
| 40-49 | 156 (16.0) | 1236 (11.5) | 1.008 (0.354-2.873) | 0.987 | ||
| 50-59 | 364 (37.4) | 3768 (35.1) | 0.838 (0.295-2.364) | 0.735 | ||
| >60 | 429 (44.1) | 5474 (50.9) | 0.688 (0.243-1.945) | 0.481 | ||
| Sex | ||||||
| Male | 541 (55.7) | 4313 (40.1) | 1.872 (1.640-2.137) | <0.001* | 1.832 (1.542-2.178) | <0.001* |
| Female | 431 (44.3) | 6432 (59.9) | 1.000 | 1.000 | ||
| Smoking | ||||||
| Current, previous | 143 (14.7) | 1249 (11.6) | 1.311 (1.088-1.581) | 0.004* | 0.917 (0.750-1.121) | 0.399 |
| Never | 829 (85.3) | 9496 (88.4) | 1.000 | 1.000 | ||
| Alcohol | ||||||
| Current, previous | 174 (17.9) | 1806 (16.8) | 1.079 (0.909-1.281) | 0.384 | ||
| Never | 798 (82.1) | 8939 (83.2) | 1.000 | |||
| Betel nut | ||||||
| Current, previous | 42 (4.3) | 415 (3.9) | 1.124 (0.813-1.555) | 0.480 | ||
| Never | 930 (95.7) | 10,330 (96.1) | 1.000 | |||
| Exercise (/week) | ||||||
| <30 min | 236 (24.3) | 2764 (25.7) | 1.000 | |||
| 30-60 | 418 (44.3) | 4171 (38.8) | 1.174 (0.994-1.387) | 0.060 | ||
| 60-180 | 176 (18.1) | 2194 (20.4) | 0.940 (0.767-1.151) | 0.547 | ||
| >180 | 130 (13.3) | 1531 (15.1) | 0.994 (0.796-1.243) | 0.961 | ||
| Systolic pressure (mmHg) | 122.4±15.1 | 122.0±15.7 | 1.002 (0.997-1.008) | 0.435 | ||
| Diastolic pressure (mmHg) | 74.2±10.6 | 73.0±13.8 | 1.005 (1.001-1.018) | 0.015* | 1.002 (0.997-1.006) | 0.433 |
| BMI (kg/m2) | ||||||
| <18.5 | 33 (3.4) | 479 (4.5) | 0.803 (0.558-1.155) | 0.237 | 0.856 (0.591-1.240) | 0.411 |
| ≥18.5, <24 | 509 (52.3) | 5931 (55.2) | 1.000 | 1.000 | ||
| ≥24, <27 | 287 (29.5) | 2763 (25.7) | 1.210 (1.040-1.408) | 0.014* | 1.136 (0.960-1.345) | 0.137 |
| ≥27, <30 | 100 (10.2) | 1109 (10.3) | 1.051 (0.840-1.314) | 0.665 | 1.014 (0.781-1.317) | 0.915 |
| ≥30, <35 | 37 (3.8) | 393 (3.7) | 1.097 (0.774-1.555) | 0.603 | 1.188 (0.808-1.745) | 0.381 |
| ≥35 | 6 (0.6) | 70 (0.6) | 0.999 (0.432-2.310) | 0.998 | 0.937 (0.396-2.219) | 0.883 |
| Waist (cm) | ||||||
| ≥80 (female), ≥90 (male) | 389 (40) | 4735 (44.1) | 0.847 (0.741-0.968) | 0.015 | 0.938 (0.791-1.113) | 0.465 |
| <80 (female), <90 (male) | 583 (60) | 6010 (55.9) | 1.000 | 1.000 | ||
| Body fat (%) | ||||||
| ≥30 (female), ≥25 (male) | 343 (35.3) | 4038 (37.6) | 0.906 (0.790-1.039) | 0.157 | ||
| <30 (female), <25 (male) | 629 (64.7) | 6707 (62.4) | 1.000 | |||
| HBsAg positive | 167 (17.2) | 1306 (12.2) | 1.498 (1.255-1.787) | <0.001* | 1.540 (1.287-1.844) | <0.001* |
| Anti-HCV positive | 15 (1.5) | 241 (2.2) | 0.683 (0.404-1.155) | 0.155 | ||
| HbA1c (%) | 5.7±0.9 | 5.7±0.8 | 0.978 (0.905-1.058) | 0.584 | ||
| Fasting glucose (mg/dL) | ||||||
| ≥100 | 390 (40.1) | 4320 (40.2) | 0.997 (0.872-1.139) | 0.961 | ||
| <100 | 582 (59.9) | 6425 (59.8) | 1.000 | |||
| Total cholesterol (mg/dL) | ||||||
| ≥240 | 51 (5.3) | 807 (7.5) | 0.638 (0.476-0.855) | 0.003* | 0.729 (0.464-1.148) | 0.173 |
| ≥200, <240 | 210 (21.6) | 2763 (25.7) | 0.767 (0.654-0.900) | 0.001* | 0.785 (0.628-0.981) | 0.033* |
| <200 | 711 (73.1) | 7175 (66.8) | 1.000 | |||
| HDL-C (mg/dL) | ||||||
| <50 (female), <40 (male) | 404 (41.6) | 4308 (40.1) | 1.063 (0.930-1.214) | 0.371 | ||
| ≥50 (female), ≥40 (male) | 568 (58.4) | 6437 (59.9) | 1.000 | |||
| LDL-C (mg/dL) | ||||||
| ≥190 | 13 (1.3) | 198 (1.9) | 0.694 (0.394-1.224) | 0.207 | 1.033 (0.502-2.125) | 0.930 |
| ≥160, <190 | 60 (6.2) | 892 (8.3) | 0.711 (0.541-0.935) | 0.015* | 1.006 (0.682-1.482) | 0.978 |
| ≥130, <160 | 233 (24) | 2611 (24.3) | 0.944 (0.808-1.103) | 0.467 | 1.142 (0.930-1.403) | 0.205 |
| <130 | 666 (68.5) | 7044 (65.6) | 1.000 | 1.000 | ||
| TG (mg/dL) | ||||||
| ≥150 | 189 (19.4) | 2177 (20.3) | 0.950 (0.805-1.121) | 0.544 | ||
| <150 | 783 (80.6) | 8568 (79.7) | 1.000 | |||
| Diet | ||||||
| Vegan group | 101 (10.4) | 1027 (9.6) | 0.926 (0.735-1.167) | 0.514 | 0.997 (0.786–1.264) | 0.978 |
| Ovo-lactovegetarian group | 483 (49.7) | 5968 (55.5) | 0.762 (0.660-0.879) | <0.001* | 0.830 (0.715–0.965) | 0.015* |
| Semi-vegetarian group | 28 (2.9) | 361 (3.4) | 0.730 (0.490-1.089) | 0.123 | 0.775 (0.518–1.159) | 0.215 |
| Omnivore group | 360 (37) | 3389 (31.5) | 1.000 | 1.000 | ||
*Statistically significant. Data are shown as n (%) or mean±SD. HBsAg: Hepatitis B virus surface antigen, HBV: Hepatitis B virus, HCV: Hepatitis C virus, HbA1c: Hemoglobin A1c, TG: Triglycerides, BMI: Body mass index, HDL-C: High-density lipoprotein-cholesterol, LDL-C: Low-density lipoprotein-cholesterol, SD: Standard deviation, OR: Odds ratio, CI: Confidence interval
Characteristics of gall bladder polyps
| Characteristic | Vegan group ( | Ovo-lactovegetarian group ( | Semi-vegetarian group ( | Omnivore group ( | |
|---|---|---|---|---|---|
| Polyp number | |||||
| Single | 66 (65.3) | 334 (69.1) | 17 (60.7) | 253 (70.2) | 0.614 |
| Multiple | 35 (34.7) | 149 (30.9) | 11 (39.3) | 107 (29.8) | |
| Polyp size (mm) | |||||
| <5 | 78 (77.2) | 359 (74.3) | 22 (78.5) | 272 (75.5) | 0.738 |
| 5-10 | 21 (20.7) | 116 (24.0) | 6 (21.5) | 86 (23.8) | |
| ≥10 | 2 (2.1) | 8 (1.7) | 0 | 2 (0.7) |